eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Abbott Laboratories Limited
Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 26/01/2012
PIL Norvir Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 09/12/2011 and displayed until 26/01/2012
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change to drug interactions
Updated on 07/09/2011 and displayed until 09/12/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 26/05/2010 and displayed until 07/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 30/04/2010 and displayed until 26/05/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/09/2009 and displayed until 30/04/2010
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
Updated on 29/07/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to name of manufacturer
  • Change to date of revision
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 21/07/2008 and displayed until 29/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 06/12/2007 and displayed until 21/07/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 22/08/2007 and displayed until 06/12/2007
Reasons for adding or updating:
  • Change to drug interactions
  • Change of contra-indications
  • Change to Further Information section
  • Change to date of revision
Updated on 12/03/2007 and displayed until 22/08/2007
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 07/03/2007 and displayed until 12/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 25/01/2007 and displayed until 07/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 22/01/2007 and displayed until 25/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 15/12/2006 and displayed until 22/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to Further Information section
Updated on 29/09/2006 and displayed until 15/12/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 11/03/2005 and displayed until 29/09/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/02/2002 and displayed until 11/03/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  ritonavir